105 related articles for article (PubMed ID: 25304265)
21. Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways.
Becker KA; Lu S; Dickinson ES; Dunphy KA; Mathews L; Schneider SS; Jerry DJ
Oncogene; 2005 Sep; 24(42):6345-53. PubMed ID: 15940247
[TBL] [Abstract][Full Text] [Related]
22. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
23. Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene.
Nielsen LL; Discafani CM; Gurnani M; Tyler RD
Cancer Res; 1991 Jul; 51(14):3762-7. PubMed ID: 2065330
[TBL] [Abstract][Full Text] [Related]
24. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
[TBL] [Abstract][Full Text] [Related]
25. Mammary tumor formation in p53- and BRCA1-deficient mice.
Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
[TBL] [Abstract][Full Text] [Related]
26. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
27. Chronic, low-level (1.0 W/kg) exposure of mice prone to mammary cancer to 2450 MHz microwaves.
Frei MR; Jauchem JR; Dusch SJ; Merritt JH; Berger RE; Stedham MA
Radiat Res; 1998 Nov; 150(5):568-76. PubMed ID: 9806599
[TBL] [Abstract][Full Text] [Related]
28. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
[TBL] [Abstract][Full Text] [Related]
29. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors.
Klopfleisch R; Klose P; Gruber AD
Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
31. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.
Barcellos-Hoff MH; Ravani SA
Cancer Res; 2000 Mar; 60(5):1254-60. PubMed ID: 10728684
[TBL] [Abstract][Full Text] [Related]
32. Chronic exposure of cancer-prone mice to low-level 2450 MHz radiofrequency radiation.
Frei MR; Berger RE; Dusch SJ; Guel V; Jauchem JR; Merritt JH; Stedham MA
Bioelectromagnetics; 1998; 19(1):20-31. PubMed ID: 9453703
[TBL] [Abstract][Full Text] [Related]
33. Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.
Kondratyev M; Kreso A; Hallett RM; Girgis-Gabardo A; Barcelon ME; Ilieva D; Ware C; Majumder PK; Hassell JA
Oncogene; 2012 Jan; 31(1):93-103. PubMed ID: 21666715
[TBL] [Abstract][Full Text] [Related]
34. Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy.
Ma L; Gonzalez-Junca A; Zheng Y; Ouyang H; Illa-Bochaca I; Horst KC; Krings G; Wang Y; Fernandez-Garcia I; Chou W; Barcellos-Hoff MH
Clin Cancer Res; 2021 Mar; 27(6):1778-1791. PubMed ID: 33402361
[TBL] [Abstract][Full Text] [Related]
35. Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation.
Yao S; Huang HY; Han X; Ye Y; Qin Z; Zhao G; Li F; Hu G; Hu L; Ji H
Oncogene; 2019 Sep; 38(36):6354-6369. PubMed ID: 31320708
[TBL] [Abstract][Full Text] [Related]
36. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
37. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS
Cancer Res; 2002 May; 62(10):2798-805. PubMed ID: 12019156
[TBL] [Abstract][Full Text] [Related]
38. Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis.
Smolen GA; Muir B; Mohapatra G; Barmettler A; Kim WJ; Rivera MN; Haserlat SM; Okimoto RA; Kwak E; Dahiya S; Garber JE; Bell DW; Sgroi DC; Chin L; Deng CX; Haber DA
Cancer Res; 2006 Apr; 66(7):3452-5. PubMed ID: 16585167
[TBL] [Abstract][Full Text] [Related]
39. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
40. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
